The impact of diabetes mellitus on two-year mortality following contemporary percutaneous coronary intervention: Implications for revascularization practice

Journal of Interventional Cardiology

Volumn 22, Issue 5, 2009, Pages 420-426

  Andron, M ^a   Perry, R A ^a   Egred, M ^a   Alahmar, A E ^a   Grayson, A D ^a   Shaw, M ^a   Roberts, E ^a   Palmer, N D ^a   Stables, R H ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DIABETIC DIET; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; STENT THROMBOSIS; TERTIARY HEALTH CARE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; COMORBIDITY; CORONARY DISEASE; CORONARY VESSELS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS;

EID: 70349739384     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00471.x     Document Type: Article

References (37)

1. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999 67 : 1045 1052.
2. Smith LR, Harrell FE Jr., Rankin JS, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991 84 (5 Suppl III245 III53.
3. Kubal C, Srinivasan AK, Grayson AD, et al. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg 2005 79 : 1570 1576.
4. Rajakaruna C, Rogers CA, Suranimala C, et al. The effect of diabetes mellitus on patients undergoing coronary surgery: A risk-adjusted analysis. J Thorac Cardiovasc Surg 2006 132 : 802 810.
5. Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998 32 : 1866 1873. (Pubitemid 29010448)
6. Labinaz M, Madan M, O'Shea JC, et al. Comparison of one-year outcomes following coronary artery stenting in diabetic versus non-diabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin therapy [ESPRIT] trial). Am J Cardiol 2002 90 : 585 590.
7. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998 32 : 584 589.
8. Mathew V, Gersh BJ, Williams BA, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: A report from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 2004 109 : 476 480.
9. Wilson SR, Vakili BA, Sherman W, et al. Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: Analysis of 4,284 cases. Diabetes Care 2004 27 : 1137 1142.
10. BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997 96 : 1761 1769.
11. Niles NW, McGrath PD, Malenka D, et al. for the Northern New England Cardiovascular Disease Study Group. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: Results of a large regional prospective study. J Am Coll Cardiol 2001 37 : 1008 1015.
12. Kip KE, Faxon DP, Detre KM, et al. for the Investigators of the NHLBI PTCA Registry. Coronary angioplasty in diabetic patients: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996 94 : 1818 1825.
13. O'Neill WW. Multivessel balloon angioplasty should be abandoned in diabetic patients! J Am Coll Cardiol 1998 31 : 20 22.
14. Abizaid A, Costa MA, Centemero M, et al. Arterial Revascularization Therapy Study Group. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001 104 : 533 538.
15. Stables RH, The SOS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery Trial). Lancet 2002 360 : 965 970.
16. Bair TL, Muhlestein JB, May HT, et al. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: Results from the Intermountain Heart Registry. Circulation 2007 116 (Suppl 11 I226 I231.
17. Kapur A, Malik IS, Bagger JP, et al. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: Background, aims, and design. Am Heart J 2005 149 : 13 19.
18. Ong AT, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase. Am Heart J 2006 151 : 1194 1204.
19. Farkouh ME, Dangas G, Leon MB, et al. Design of the Future Revascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial. Am Heart J 2008 155 : 215 223.
20. Silva JA, Escobar A, Collins TJ, et al. Unstable angina: A comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation 1995 92 : 1731 1736.
21. Deedwania PC. The deadly quartet revisited. Am J Med 1998 105 : 1S 3S.
22. Moreno PR, Murcia AM, Palacios IF, et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000 102 : 2180 2184.
23. Laskey W, Selzer F, Vlachos H, et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2002 90 : 1062 1067.
24. King SB III., Dangas G, Moses JW, et al. Surgery is preferred for the diabetic with multivessel disease. Circulation 2005 112 : 1500 1515.
25. Colombo A. Arterial revascularization therapy study part II (ARTS II): Sirolimus-eluting stent for the treatment of patients with multivessel de novo coronary artery lesions. Diabetic subgroup analysis data. Presented at 2005 EuroPCR Congress.
26. Van Belle E, Perie M, Braune D, et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 2002 40 : 410 417.
27. Grundy SM, et al. National Heart, Lung, and Blood Institute, American College of Cardiology Foundation and American Heart Association. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004 110 : 227 239.
28. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. J Am Coll Cardiol 2006 47 : 2130 2139.
29. Mehta S, Yusuf S, Peters RJG, et al. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001 358 : 527 533.
30. Steinhubl SR, Berger PB, Mann JT 3rd., et al. for the CREDO Investigators. Clopidogrel for the reduction of events during observation: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomised controlled trial. JAMA 2002 288 : 2411 2420.
31. Marso S, Lincoff A, Ellis S, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation 1999 100 : 2477 2484.
32. Yusuf S, Sleight P, Pogue J, et al. for the Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000 342 : 145 153. (Pubitemid 30051645)
33. Leavitt BJ, Sheppard L, Maloney C, et al. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 2004 110 (suppl 1 II-41 II-44.
34. Breeman A, Bertrand ME, Ottervanger JP, et al. Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease. Diabetes Care 2006 29 : 2003 2011. (Pubitemid 44871178)
35. Savage S, Estacio RO, Jeffers B, et al. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996 19 : 1243 1248.
36. de Zeeuw D, Remuzzi G, Parving HH, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004 110 : 921 927. (Pubitemid 39128617)
37. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol 2006 17 : 2106 2111.